n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine has been researched along with phenylhydrazine in 1 studies
Studies (n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine) | Trials (n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine) | Recent Studies (post-2010) (n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine) | Studies (phenylhydrazine) | Trials (phenylhydrazine) | Recent Studies (post-2010) (phenylhydrazine) |
---|---|---|---|---|---|
79 | 1 | 16 | 921 | 0 | 110 |
Protein | Taxonomy | n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine (IC50) | phenylhydrazine (IC50) |
---|---|---|---|
Cytochrome P450 1A2 | Homo sapiens (human) | 8 | |
Cytochrome P450 3A4 | Homo sapiens (human) | 0.9 | |
Cytochrome P450 2D6 | Homo sapiens (human) | 3 | |
Cytochrome P450 2C9 | Homo sapiens (human) | 6 | |
Polyunsaturated fatty acid lipoxygenase ALOX15 | Oryctolagus cuniculus (rabbit) | 1.666 | |
Indoleamine 2,3-dioxygenase 1 | Homo sapiens (human) | 0.5933 | |
Indoleamine 2,3-dioxygenase 1 | Mus musculus (house mouse) | 0.2 | |
Cytochrome P450 2C19 | Homo sapiens (human) | 5 | |
Prostaglandin G/H synthase 2 | Homo sapiens (human) | 1.514 | |
Mu-type opioid receptor | Mus musculus (house mouse) | 0.25 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fagan, JM; Waxman, L | 1 |
1 other study(ies) available for n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine and phenylhydrazine
Article | Year |
---|---|
The ATP-independent pathway in red blood cells that degrades oxidant-damaged hemoglobin.
Topics: Adenosine Triphosphate; Animals; Azides; Calcimycin; Cations, Divalent; Cysteine Proteinase Inhibitors; Edetic Acid; Electrophoresis, Polyacrylamide Gel; Erythrocytes; Hemoglobins; Hydrogen Peroxide; Ionomycin; Kinetics; Leucine; Male; Oxidants; Phenylhydrazines; Pyrimidinones; Rabbits; Rats | 1992 |